Methylated septin 9 as a progression parameter in colorectal cancer compared to CEA and CA19-9
Publicado en: | Oncology research and treatment 45(2022)Suppl. 3 |
---|---|
Autores principales: | Schulz, Laura (Autor), Leerhoff, Sabine (Autor), Kolbe, Ernst-Wolfgang (Autor), Raem, Arnold M. (Autor), Winde, Günther (Autor) |
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://doi.org/10.1159/000521004 |
Publicación relacionada: | In:
Oncology research and treatment |
Ejemplares similares
-
Inflammatory markers and extent and progression of early atherosclerosis : Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
por: Willeit, Peter, et al.
Publicado: (2016) -
Carotid intima-media thickness progression as surrogate marker for cardiovascular risk : analysis of 119 clinical trials involving 100667 patients
por: Willeit, Peter, et al.
Publicado: (2020) -
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease
por: Charytan, David M, et al.
Publicado: (2016) -
Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?
por: Liao, Ximing, et al.
Publicado: (2016) -
Carotid intima-media thickness progression and risk of vascular events in people with diabetes : results from the PROG-IMT collaboration
por: Lorenz, Matthias W., et al.
Publicado: (2015)